---
document_datetime: 2023-09-21 18:50:46
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/taxotere-epar-all-authorised-presentations_en.pdf
document_name: taxotere-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0770036
conversion_datetime: 2025-12-27 17:08:05.729997
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength     | Pharmaceutical Form                               | Route of Administration   | Packaging                                        | Content (concentration)              | Package size    |
|-----------------|-----------------|--------------|---------------------------------------------------|---------------------------|--------------------------------------------------|--------------------------------------|-----------------|
| EU/1/95/002/001 | Taxotere        | 20 mg/0.5 ml | Concentrate and solvent for solution for infusion | Intravenous use           | concentrate: vial (glass); solvent: vial (glass) | concentrate: 0.5 ml; solvent: 1.5 ml | 1 vial + 1 vial |
| EU/1/95/002/002 | Taxotere        | 80 mg/2 ml   | Concentrate and solvent for solution for infusion | Intravenous use           | concentrate: vial (glass); solvent: vial (glass) | concentrate: 2 ml; solvent: 6 ml     | 1 vial + 1 vial |
| EU/1/95/002/003 | Taxotere        | 20 mg/1 ml   | Concentrate for solution for infusion             | Intravenous use           | vial (glass)                                     | 1 ml                                 | 1 vial          |
| EU/1/95/002/004 | Taxotere        | 80 mg/4 ml   | Concentrate for solution for infusion             | Intravenous use           | vial (glass)                                     | 4 ml                                 | 1 vial          |
| EU/1/95/002/005 | Taxotere        | 160 mg/8 ml  | Concentrate for solution for infusion             | Intravenous use           | vial (glass)                                     | 8 ml                                 | 1 vial          |